Frost & Sullivan Presents the "GLOBAL CARDIOVASCULAR, CEREBROVASCULAR AND RESPIRATORY NEW DRUG R&D COMPANY OF THE YEAR" Award to Chengdu Shibeikang Biomedical Technology Co., Ltd.
Shanghai, China--(Newsfile Corp. - September 16, 2026) - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) Summit and the 5th New Investment Event (the "2026 Frost & Sullivan New Investment Event") officially opened at Jing An Shangri-La, Shanghai. During the event, the 2026 Frost & Sullivan Global Awards and China Awards were announced.Based on its evaluation process, including industry research and assessment of companies in the cardiovascular,...